endometrial carcinoma


Also found in: Thesaurus, Medical, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.endometrial carcinoma - cancer of the uterine lining
carcinoma - any malignant tumor derived from epithelial tissue; one of the four major types of cancer
References in periodicals archive ?
The expression pattern of 19 genes predicts the histology of endometrial carcinoma.
Shortly thereafter, Bokhman proposed two broad categories of endometrial carcinoma characterized by distinct microscopic appearance, epidemiology, and endocrine and metabolic functioning (TABLE, page 28).
Objective: To determine the accuracy of Doppler ultrasound in the diagnosis of endometrial carcinoma in patients presenting with post-menopausal bleeding while taking histopathological findings as the gold standard.
In patients with cellular atypia, 25% have foci of endometrial carcinoma or will develop it at some point in the future, which compares to 2% in patients without cellular atypia.
Given the improved side effect profile, vaginal brachytherapy should be the "treatment of choice" for patients with high-intermediate risk of endometrial carcinoma, Dr.
A phase Ib/II trial of lenvatinib (LEN) plus pembrolizumab (Pembro) in patients (Pts) with endometrial carcinoma.
5] In premenopausal women, with normal findings on physical examination, the most likely diagnosis is DUB secondary to anovulation and in postmenopausal females, uterine pathology, especially endometrial carcinoma is a common cause of DUB.
Extent of p53-specific nuclear immunostaining can be used to assess p53 gene integrity in endometrial carcinoma.
Endometrial carcinoma is a common gynecologic malignancy that typically affects post-menopausal women during their 6th or 7th decade of life.
4) Stovall performed such outpatient biopsy on 40 patients with known carcinoma the week prior to scheduled hysterectomy and obtained endometrial carcinoma in 39 of the 40 samples; he reported a 97.
Kenilworth, NJ, USA (known as MSD outside of the United States and Canada) to increase the target number of endometrial carcinoma patients to be enrolled in a Phase Ib/II clinical study of its in-house discovered and developed multi-kinase inhibitor lenvatinib mesylate (product names: Lenvima / Kisplyx, lenvatinib) in combination with anti-PD-1 therapy pembrolizumab (brand name: KEYTRUDA), developed by Merck & Co.
She had a significant positive family history as one 1st cousin died with breast cancer, and her aunt had synchronous breast and endometrial carcinoma.